IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

MKS INC (MKSI)

Business Summary

MKS Inc. delivers foundational technology solutions to leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications. The semiconductor market is subject to rapid demand shifts, and the semiconductor capital equipment industry has recently been subject to significant trade restrictions, especially in key markets, including China. The electronics and packaging market demands smaller features, greater density, and better performance, and the specialty industrial market encompasses industrial, life and health sciences, and research and defense applications. The company believes there are three secular trends benefiting MKS: the impact of an increasingly interconnected world, the increasing complexity of technology transitions in semiconductor, PCB and package substrate manufacturing, and the accelerating need for laser-based precision manufacturing techniques.

MKS believes it is the broadest critical subsystem provider in the wafer fabrication equipment ecosystem and addresses over 85% of the market. The company's top ten customers accounted for 35% , 32% and 30% of net revenues for 2025, 2024 and 2023, respectively. None of the customers in 2025, 2024 or 2023 accounted for greater than 10% of net revenues. Competitors include Advanced Energy Industries, Inc., Inficon, Inc., Hitachi Ltd., Horiba Ltd., Brooks Instrument, VAT, Inc., Trumpf Group, Lumentum Holdings Inc., IPG Photonics Corporation, Coherent Corp., Element Solutions Inc., and others, though no single competitor competes across all product lines.

MKS generates revenue through the sale of products and services across three divisions: Vacuum Solutions Division (VSD), Photonics Solutions Division (PSD), and Materials Solutions Division (MSD). Net product revenues were $3,436 million and net service revenues were $495 million in 2025. The company's offerings include instruments, subsystems, systems, process control solutions and specialty chemicals technology. The company has developed two product strategies: Surround the Wafer for semiconductor customers and Surround the Workpiece for laser-based guidance and control, with an extension called Optimize the Interconnect for PCB and package substrate manufacturing.

VSD delivers foundational technology solutions for semiconductor manufacturing, electronics and packaging and specialty industrial applications, with products derived from core competencies in vacuum technologies including pressure measurement and control, flow measurement and control, gas and vapor delivery, gas composition analysis, electronic control technology, reactive gas generation and delivery, power generation and delivery, and fiber optic temperature and position sensing. VSD net revenues were $1,579 million in 2025. PSD provides a broad range of instruments, components and subsystems, with products derived from core competencies in lasers, photonics, optics, precision motion control and vibration control, including laser products, photonics products, and laser-based systems for PCB manufacturing. PSD net revenues were $1,029 million in 2025. MSD develops leading process and manufacturing technologies for advanced surface modification, electroless and electrolytic plating, and surface finishing, with a portfolio including chemistry, equipment and services. MSD net revenues were $1,323 million in 2025. Global Service includes installation services, on-site services, technical support, repair and calibration services, and warranties typically ranging from one to three years.

In 2025, MKS repurchased approximately 546,000 shares of its common stock for total consideration of $45 million . The company paid cash dividends of $59 million or $0.88 per share in 2025. On February 9, 2026, the Board of Directors declared a quarterly cash dividend of $0.25 per share. In 2025, the company recorded restructuring and other charges of $37 million , primarily related to severance costs from a global cost saving initiative implemented during the first quarter of 2025. The company entered into the Fifth Amendment to Credit Agreement on January 24, 2025, and made voluntary prepayments of $100 million principal amount to the USD Tranche B loan in each of January, June, August and October 2025. On February 4, 2026, the company completed a private offering of €1.0 billion aggregate principal amount of senior notes due 2034 and entered into the Sixth Amendment to Credit Agreement.

Total net revenues for 2025 were $3,931 million , compared to $3,586 million in 2024. Net income was $295 million in 2025, compared to $190 million in 2024. Diluted EPS was $4.37 in 2025 versus $2.81 in 2024. Gross profit as a percentage of net revenues was 46.7% in 2025, compared to 47.6% in 2024. Net cash provided by operating activities was $645 million in 2025. International net revenues accounted for approximately 81% of total net revenues in 2025.

Business Outlook & Financial Sufficiency

MKS is investing in product advancements designed to address industry trends such as the rising demand for more complex hardware architecture related to increasing investments in artificial intelligence, the shrinking of integrated circuit critical dimensions and technology inflections, and the transition to larger substrate sizes in the flat panel display and solar markets. The company continues to develop products that support the migration to new classes of materials, ultra-thin layers, and 3D structures used in small geometry manufacturing. In the chemistry and equipment plating businesses, a majority of research and development investment supports existing customers' product improvement needs and short-term research and development goals.

MKS is building significant manufacturing facilities located in Penang, Malaysia, Yangzhou, China and Bangkok, Thailand. The company is also relocating manufacturing of certain product lines to facilities in Mexico, Romania and Singapore, as well as to subcontracted operations in Mexico and selected contract manufacturers in Asia. The company has relocated certain procurement activity to Mexico and Romania, certain IT and research and development activity to India, certain administrative finance, payroll, software and IT activity to Poland, and continues certain engineering activity in India.

Research and development expenses were $299 million in 2025. Capital expenditures were $148 million in 2025, primarily related to new facility additions in Malaysia and China. The company repurchased approximately 546,000 shares of its common stock for total consideration of $45 million in 2025. The Board of Directors declared a quarterly cash dividend of $0.25 per share on February 9, 2026. The company has a share repurchase program for the repurchase of up to an aggregate of $200 million of outstanding common stock, with approximately $172 million repurchased since its adoption.

The company faces structural headwinds from significant trade restrictions, especially in key markets including China, which have impacted sales. The U.S. government imposed tariffs on certain imports from China, with U.S. duties on Chinese imports reaching a peak of 145% in early 2025. As of January 2026, the company remains subject to a combined 20% IEEPA-based baseline duty on Chinese imports. The BIS Rules have resulted in an annual loss in net revenues of approximately $200 million to $250 million , most of which was realized in 2023. The company also faces risks from unfavorable currency exchange rate fluctuations, with a significant portion of net revenues from international markets where invoicing occurs in currencies other than the U.S. dollar.

The semiconductor, electronics manufacturing and automotive industries are characterized by periodic fluctuations in business activity. The company's year-over-year sales to semiconductor capital equipment manufacturers and semiconductor device manufacturers increased 13% in 2025, increased 1% in 2024 and decreased 28% in 2023. The company faces risks from rapid technological change, narrow design windows, and the need to introduce new and innovative products. The company also faces risks from supply chain disruptions, sole and limited source suppliers, and the transition of manufacturing to other locations.

Management Sentiments & Priorities

Management's message emphasizes that MKS enables technologies that transform the world, delivering foundational technology solutions to leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications. The company's solutions are critical to addressing the challenges of miniaturization and complexity in advanced device manufacturing. Management highlights the company's broad science and engineering capabilities to create instruments, subsystems, systems, process control solutions and specialty chemicals technology. The company continues to implement strategies to strengthen supplier diversification, explore alternative sourcing geographies and optimize logistics routes to mitigate cost impacts from the evolving global trade landscape. Management notes that the company's research and development efforts are focused on developing and improving products to improve process performance and productivity, with research and development expenses of $299 million in 2025.

Financial Details

Total net revenues were $3,931 million for 2025, compared to $3,586 million for 2024. Net income was $295 million for 2025, compared to $190 million for 2024. Diluted EPS was $4.37 for 2025 versus $2.81 for 2024. Income from operations was $528 million for 2025, compared to $498 million for 2024. Gross profit as a percentage of net revenues was 46.7% for 2025, compared to 47.6% for 2024. Net cash provided by operating activities was $645 million for 2025. Cash and cash equivalents were $675 million as of December 31, 2025, compared to $714 million as of December 31, 2024. Long-term debt, net was $4,150 million as of December 31, 2025. The company recorded restructuring and other charges of $37 million in 2025, primarily related to severance costs. Interest expense, net was $198 million in 2025, compared to $263 million in 2024. The effective tax rate was 2.9% for 2025. VSD net revenues were $1,579 million in 2025, PSD net revenues were $1,029 million , and MSD net revenues were $1,323 million .

Risk Factors

The company's substantial consolidated indebtedness could adversely affect it, with approximately $1.6 billion of principal indebtedness outstanding under the Term Loan Facility as of February 4, 2026, and $1.4 billion aggregate principal amount of Convertible Notes. The company recorded goodwill and intangible asset impairments of $1.9 billion in 2023, and as of December 31, 2025, goodwill and intangible assets represented approximately $4.7 billion or 54% of total assets. The BIS Rules have resulted in an annual loss in net revenues of approximately $200 million to $250 million , most of which was realized in 2023. The company's top ten customers accounted for 35% of net revenues in 2025, and the loss of any major customer would likely have a material adverse effect. The company faces significant risks from doing business in China, including adverse changes in political or economic conditions, and from the escalation of trade tensions, with U.S. duties on Chinese imports reaching a peak of 145% in early 2025.

References

  1. [1] Item 1, Business — Customers
  2. [2] Item 1, Business — Customers
  3. [3] Item 1, Business — Customers
  4. [4] Item 7, MD&A — Results of Operations
  5. [5] Item 7, MD&A — Results of Operations
  6. [6] Item 7, MD&A — Results of Operations
  7. [7] Item 7, MD&A — Results of Operations
  8. [8] Item 7, MD&A — Results of Operations
  9. [9] Item 5, Market for Registrant's Common Equity — Share Repurchase Program
  10. [10] Item 5, Market for Registrant's Common Equity — Share Repurchase Program
  11. [11] Item 5, Market for Registrant's Common Equity — Dividend Policy
  12. [12] Item 5, Market for Registrant's Common Equity — Dividend Policy
  13. [13] Item 5, Market for Registrant's Common Equity — Dividend Policy
  14. [14] Item 7, MD&A — Restructuring and other
  15. [15] Item 7, MD&A — Liquidity and Capital Resources
  16. [16] Item 7, MD&A — 2034 Notes
  17. [17] Item 8, Consolidated Statements of Operations
  18. [18] Item 8, Consolidated Statements of Operations
  19. [19] Item 8, Consolidated Statements of Operations
  20. [20] Item 8, Consolidated Statements of Operations
  21. [21] Item 8, Consolidated Statements of Operations
  22. [22] Item 8, Consolidated Statements of Operations
  23. [23] Item 7, MD&A — Results of Operations
  24. [24] Item 7, MD&A — Results of Operations
  25. [25] Item 7, MD&A — Liquidity and Capital Resources
  26. [26] Item 7, MD&A — International Markets
  27. [27] Item 7, MD&A — Research and Development
  28. [28] Item 7, MD&A — Liquidity and Capital Resources
  29. [29] Item 5, Market for Registrant's Common Equity — Share Repurchase Program
  30. [30] Item 5, Market for Registrant's Common Equity — Share Repurchase Program
  31. [31] Item 5, Market for Registrant's Common Equity — Dividend Policy
  32. [32] Item 5, Market for Registrant's Common Equity — Share Repurchase Program
  33. [33] Item 5, Market for Registrant's Common Equity — Share Repurchase Program
  34. [34] Item 1A, Risk Factors — Trade Restrictions
  35. [35] Item 1A, Risk Factors — Trade Restrictions
  36. [36] Item 1A, Risk Factors — Trade Restrictions
  37. [37] Item 1, Business — Semiconductor Market
  38. [38] Item 1, Business — Semiconductor Market
  39. [39] Item 1, Business — Semiconductor Market
  40. [40] Item 1A, Risk Factors — Financial Risks
  41. [41] Item 1A, Risk Factors — Financial Risks
  42. [42] Item 1A, Risk Factors — Strategic Transaction Risks
  43. [43] Item 1A, Risk Factors — Financial Risks
  44. [44] Item 1A, Risk Factors — Financial Risks
  45. [45] Item 1A, Risk Factors — Trade Restrictions
  46. [46] Item 1, Business — Customers
  47. [47] Item 1A, Risk Factors — Trade Restrictions
  48. [48] Item 7, MD&A — Research and Development
  49. [49] Item 8, Consolidated Statements of Operations
  50. [50] Item 8, Consolidated Statements of Operations
  51. [51] Item 8, Consolidated Statements of Operations
  52. [52] Item 8, Consolidated Statements of Operations
  53. [53] Item 8, Consolidated Statements of Operations
  54. [54] Item 8, Consolidated Statements of Operations
  55. [55] Item 8, Consolidated Statements of Operations
  56. [56] Item 8, Consolidated Statements of Operations
  57. [57] Item 7, MD&A — Results of Operations
  58. [58] Item 7, MD&A — Results of Operations
  59. [59] Item 7, MD&A — Liquidity and Capital Resources
  60. [60] Item 8, Consolidated Balance Sheets
  61. [61] Item 8, Consolidated Balance Sheets
  62. [62] Item 8, Consolidated Balance Sheets
  63. [63] Item 7, MD&A — Restructuring and other
  64. [64] Item 7, MD&A — Interest Expense, Net
  65. [65] Item 7, MD&A — Interest Expense, Net
  66. [66] Item 7, MD&A — Provision (Benefit) for Income Taxes
  67. [67] Item 7, MD&A — Results of Operations
  68. [68] Item 7, MD&A — Results of Operations
  69. [69] Item 7, MD&A — Results of Operations

Analysis on 6/8/2026